Adagio Medical Financials
This page shows Adagio Medical (ADGM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Adagio Medical held $20.6M in cash against $17.2M in long-term debt as of fiscal year 2024.
Adagio Medical had 15M shares outstanding in fiscal year 2024. This represents an increase of 1848.7% from the prior year.
ADGM Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | N/A | N/A | $132K-48.0% | $254K+876.9% | $26K | N/A | $41K |
| Cost of Revenue | $31K-90.9% | $342K+35.2% | $253K-38.9% | $414K-39.3% | $682K+25.8% | $542K | N/A | $253K |
| Gross Profit | -$31K | N/A | N/A | -$282K+34.1% | -$428K+17.1% | -$516K | N/A | -$212K |
| R&D Expenses | $2.8M+40.7% | $2.0M-46.1% | $3.7M+200.7% | $1.2M-57.5% | $2.9M-17.4% | $3.5M | N/A | $4.4M |
| SG&A Expenses | $2.9M+21.3% | $2.4M-31.0% | $3.5M+19.1% | $2.9M-13.1% | $3.4M-30.3% | $4.8M | N/A | $4.5M |
| Operating Income | -$5.7M-21.3% | -$4.7M+36.2% | -$7.4M-67.2% | -$4.4M+33.5% | -$6.7M+24.5% | -$8.8M | N/A | -$9.1M |
| Interest Expense | $749K+4.0% | $720K+8.8% | $662K+52.2% | $435K-42.8% | $760K+0.8% | $754K | N/A | $485K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$10.1M-156.3% | -$3.9M+48.8% | -$7.7M-313.9% | $3.6M+162.9% | -$5.7M+28.5% | -$8.0M | N/A | -$10.8M |
| EPS (Diluted) | $-0.66-88.6% | $-0.35+31.4% | $-0.51-2650.0% | $0.02+100.3% | $-7.35+28.5% | $-10.28 | N/A | $-14.15 |
ADGM Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.5M-12.1% | $35.9M-13.2% | $41.3M-14.7% | $48.4M+134.5% | -$140.5M | N/A | $6.8M | N/A |
| Current Assets | $8.1M-33.4% | $12.2M-29.6% | $17.4M-31.5% | $25.3M | N/A | N/A | $5.2M | N/A |
| Cash & Equivalents | $4.7M-43.0% | $8.2M-36.7% | $13.0M-37.0% | $20.6M+906.7% | $2.0M-49.9% | $4.1M+195.2% | $1.4M-30.2% | $2.0M |
| Inventory | $1.5M-15.9% | $1.8M-20.3% | $2.3M-10.0% | $2.6M | N/A | N/A | $3.3M | N/A |
| Accounts Receivable | N/A | N/A | $1K-97.1% | $35K | N/A | N/A | $71K | N/A |
| Goodwill | $14.0M0.0% | $14.0M0.0% | $14.0M0.0% | $14.0M | N/A | N/A | $0 | N/A |
| Total Liabilities | $32.9M+20.8% | $27.2M-6.0% | $28.9M+1.4% | $28.5M+570620.0% | $5K | N/A | $138.8M | N/A |
| Current Liabilities | $9.7M+98.6% | $4.9M-18.7% | $6.0M-22.6% | $7.8M | N/A | N/A | $47.2M | N/A |
| Long-Term Debt | $21.2M+25.1% | $16.9M-4.0% | $17.7M+2.7% | $17.2M | N/A | N/A | $38.3M | N/A |
| Total Equity | -$1.3M-115.1% | $8.7M-30.1% | $12.4M-37.7% | $19.9M+114.2% | -$140.5M-0.9% | -$139.2M-5.4% | -$132.0M-6.9% | -$123.5M |
| Retained Earnings | -$92.3M-12.3% | -$82.2M-5.0% | -$78.3M-10.9% | -$70.6M-3199.6% | -$2.1M | N/A | -$133.6M | N/A |
ADGM Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.0M+35.4% | -$4.7M+35.4% | -$7.2M-1.4% | -$7.1M+23.1% | -$9.3M-37.3% | -$6.7M+5.0% | -$7.1M | N/A |
| Capital Expenditures | $520K+5100.0% | $10K-97.0% | $335K-52.3% | $702K+240.8% | $206K+27.2% | $162K+710.0% | $20K | N/A |
| Free Cash Flow | -$3.5M+24.4% | -$4.7M+38.2% | -$7.5M+3.4% | -$7.8M+17.4% | -$9.5M-37.0% | -$6.9M+3.0% | -$7.1M | N/A |
| Investing Cash Flow | -$520K-5100.0% | -$10K+97.0% | -$335K+52.3% | -$702K-240.8% | -$206K-27.2% | -$162K-710.0% | -$20K | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | $6.1M-36.7% | $9.6M+45.5% | $6.6M | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ADGM Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | -213.6%-45.1pp | -168.5%+1816.1pp | -1984.6% | N/A | -517.1% |
| Operating Margin | N/A | N/A | N/A | -3352.3%-730.6pp | -2621.7%+31282.2pp | -33903.8% | N/A | -22148.8% |
| Net Margin | N/A | N/A | N/A | 2731.8%+4989.3pp | -2257.5%+28581.0pp | -30838.5% | N/A | -26246.3% |
| Return on Equity | N/A | N/A | N/A | 4.7% | N/A | N/A | N/A | N/A |
| Return on Assets | -32.1%-21.1pp | -11.0%+7.7pp | -18.7%-22.0pp | 3.4%-0.7pp | 4.1% | N/A | N/A | N/A |
| Current Ratio | 0.84-1.7 | 2.50-0.4 | 2.89-0.4 | 3.27 | N/A | N/A | 0.11 | N/A |
| Debt-to-Equity | -16.15-18.1 | 1.96+0.5 | 1.42+0.6 | 0.86+0.9 | 0.00 | N/A | -0.29 | N/A |
| FCF Margin | N/A | N/A | N/A | -5254.5%-1531.3pp | -3723.2%+22819.1pp | -26542.3% | N/A | N/A |
Similar Companies
Frequently Asked Questions
How much debt does Adagio Medical have?
As of fiscal year 2024, Adagio Medical (ADGM) had $20.6M in cash and equivalents against $17.2M in long-term debt.
What are Adagio Medical's total assets?
Adagio Medical (ADGM) had $48.4M in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Adagio Medical have outstanding?
Adagio Medical (ADGM) had 15M shares outstanding as of fiscal year 2024.
What is Adagio Medical's current ratio?
Adagio Medical (ADGM) had a current ratio of 3.27 as of fiscal year 2024, which is generally considered healthy.
What is Adagio Medical's debt-to-equity ratio?
Adagio Medical (ADGM) had a debt-to-equity ratio of 0.86 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.